Odiparcil, a potential glycosaminoglycans clearance therapy in mucopolysaccharidosis VI—Evidence from in vitro and in vivo models
Published 2020 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Odiparcil, a potential glycosaminoglycans clearance therapy in mucopolysaccharidosis VI—Evidence from in vitro and in vivo models
Authors
Keywords
Fibroblasts, Kidneys, Cartilage, Cell cultures, White blood cells, Mouse models, Lysosomes, Trachea
Journal
PLoS One
Volume 15, Issue 5, Pages e0233032
Publisher
Public Library of Science (PLoS)
Online
2020-05-16
DOI
10.1371/journal.pone.0233032
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Therapeutic Options for Mucopolysaccharidoses: Current and Emerging Treatments
- (2019) Kazuki Sawamoto et al. DRUGS
- The Lysosomal Protein Arylsulfatase B Is a Key Enzyme Involved in Skeletal Turnover
- (2018) Sandra Pohl et al. JOURNAL OF BONE AND MINERAL RESEARCH
- Mucopolysaccharidosis VI pathophysiology diagnosis and treatment
- (2017) Paul Harmatz Frontiers in Bioscience-Landmark
- A glycan-based approach to therapeutic angiogenesis
- (2017) Jie Shi Chua et al. PLoS One
- Emerging drugs for the treatment of mucopolysaccharidoses
- (2016) Roberto Giugliani et al. EXPERT OPINION ON EMERGING DRUGS
- Xyloside-primed Chondroitin Sulfate/Dermatan Sulfate from Breast Carcinoma Cells with a Defined Disaccharide Composition Has Cytotoxic Effectsin Vitro
- (2016) Andrea Persson et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Immune response to enzyme replacement therapies in lysosomal storage diseases and the role of immune tolerance induction
- (2016) Priya S. Kishnani et al. MOLECULAR GENETICS AND METABOLISM
- Targeting of Proteoglycan Synthesis Pathway: A New Strategy to Counteract Excessive Matrix Proteoglycan Deposition and Transforming Growth Factor-β1-Induced Fibrotic Phenotype in Lung Fibroblasts
- (2016) Irfan Shaukat et al. PLoS One
- The clinical spectrum and pathophysiology of skeletal complications in lysosomal storage disorders
- (2015) Lorne A. Clarke et al. BEST PRACTICE & RESEARCH CLINICAL ENDOCRINOLOGY & METABOLISM
- A straightforward, quantitative ultra-performance liquid chromatography‐tandem mass spectrometric method for heparan sulfate, dermatan sulfate and chondroitin sulfate in urine: An improved clinical screening test for the mucopolysaccharidoses
- (2015) Haoyue Zhang et al. MOLECULAR GENETICS AND METABOLISM
- A modified liquid chromatography/tandem mass spectrometry method for predominant disaccharide units of urinary glycosaminoglycans in patients with mucopolysaccharidoses
- (2014) Chih-Kuang Chuang et al. Orphanet Journal of Rare Diseases
- Biosynthesis and function of chondroitin sulfate
- (2013) Tadahisa Mikami et al. BIOCHIMICA ET BIOPHYSICA ACTA-GENERAL SUBJECTS
- Allo-Immune Membranous Nephropathy and Recombinant Aryl Sulfatase Replacement Therapy: A Need for Tolerance Induction Therapy
- (2013) H. Debiec et al. JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY
- A New C-Xyloside Induces Modifications of GAG Expression, Structure and Functional Properties
- (2012) Emilie Vassal-Stermann et al. PLoS One
- β-d-Xylosides Stimulate GAG Synthesis in Chondrocyte Cultures Due to Elevation of the Extracellular GAG Domains, Accompanied by the Depletion of the Intra–pericellular GAG Pools, with Alterations in the GAG Profiles
- (2011) Talia Weinstein et al. CONNECTIVE TISSUE RESEARCH
- Cardiovascular manifestations of mucopolysaccharidosis type VI (Maroteaux–Lamy syndrome)
- (2011) Adam Golda et al. INTERNATIONAL JOURNAL OF CARDIOLOGY
- Cardiac disease in patients with mucopolysaccharidosis: presentation, diagnosis and management
- (2011) Elizabeth A. Braunlin et al. JOURNAL OF INHERITED METABOLIC DISEASE
- Anti-TNF-Alpha Therapy Enhances the Effects of Enzyme Replacement Therapy in Rats with Mucopolysaccharidosis Type VI
- (2011) Efrat Eliyahu et al. PLoS One
- Exogenous Addition of a C-Xylopyranoside Derivative Stimulates Keratinocyte Dermatan Sulfate Synthesis and Promotes Migration
- (2011) Jun Muto et al. PLoS One
- Pathogenesis of skeletal and connective tissue involvement in the mucopolysaccharidoses: glycosaminoglycan storage is merely the instigator
- (2011) L. A. Clarke RHEUMATOLOGY
- Golgi Glycosylation
- (2011) P. Stanley Cold Spring Harbor Perspectives in Biology
- Mucopolysaccharidosis VI
- (2010) Vassili Valayannopoulos et al. Orphanet Journal of Rare Diseases
- Glycosaminoglycan-Mediated Loss of Cathepsin K Collagenolytic Activity in MPS I Contributes to Osteoclast and Growth Plate Abnormalities
- (2009) Susan Wilson et al. AMERICAN JOURNAL OF PATHOLOGY
- Involvement of the Toll-like receptor 4 pathway and use of TNF- antagonists for treatment of the mucopolysaccharidoses
- (2009) C. M. Simonaro et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Inhibition of Heparan Sulfate and Chondroitin Sulfate Proteoglycan Biosynthesis
- (2008) Dinesh R. Garud et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Characterization of Total Plasma Glycosaminoglycan Levels in Healthy Volunteers Following Oral Administration of a Novel Antithrombotic Odiparcil With Aspirin or Enoxaparin
- (2008) Alan L. Myers et al. JOURNAL OF CLINICAL PHARMACOLOGY
- Heparin cofactor II–thrombin complex: A biomarker of MPS disease
- (2008) Derrick R. Randall et al. MOLECULAR GENETICS AND METABOLISM
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started